GAPDH anticorps

N° du produit ABIN933343

Détail du produit anti-GAPDH anticorps

Antigène: GAPDH (Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp GAPDH est non-conjugé

Application: Western Blotting (WB), ELISA, Dot Blot (DB)

Réactivité croisée: Souris, Rat (Rattus), Lapin, Poulet, Hamster

Purification: Protein A affinity chromatography

Immunogène: GAPDH antibody was raised in mouse using recombinant GAPDH as the immunogen.

Clone: GA1R

Isotype: IgG1

Information d'application

Indications d'application: WB: 1:1000-100,000
Optimal conditions should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: Lot specific

Buffer: Supplied as a liquid in 10 mM PBS, pH 7.2, with 0.05 % NaN3

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Conseil sur la manipulation: Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use.

Stock: 4 °C/-20 °C

Stockage commentaire: Store at 4 °C for several days to weeks. Add 0.1 % NaN3 and store at -20 °C for longer periods.

Références pour anticorps anti-GAPDH (ABIN933343)

Dees, Pontiggia, Jasmin, Sotgia, Lisanti, Mercier: "Essential role of STAT5a in DCIS formation and invasion following estrogen treatment." dans: Aging, Vol. 12, Issue 14, pp. 15104-15120, (2020) (PubMed).

Contreras, Calderon, Varela-Ramirez, Zhang, Quan, Das, Dimmock, Skouta, Aguilera: "Induction of apoptosis via proteasome inhibition in leukemia/lymphoma cells by two potent piperidones." dans: Cellular oncology (Dordrecht), Vol. 41, Issue 6, pp. 623-636, (2018) (PubMed).

Mirzamohammadi, Kozlova, Papaioannou, Paltrinieri, Ayturk, Kobayashi: "Distinct molecular pathways mediate Mycn and Myc-regulated miR-17-92 microRNA action in Feingold syndrome mouse models." dans: Nature communications, Vol. 9, Issue 1, pp. 1352, (2018) (PubMed).

Papaioannou, Mirzamohammadi, Lisse, Nishimori, Wein, Kobayashi: "MicroRNA-140 provides robustness to the regulation of hypertrophic chondrocyte differentiation by the PTHrP-HDAC4 pathway." dans: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, (2014) (PubMed).

Wright, Wu, Dahl, Sazama, OConnell: "Nuclear localization drives ?1-adrenergic receptor oligomerization and signaling in cardiac myocytes." dans: Cellular signalling, Vol. 24, Issue 3, pp. 794-802, (2012) (PubMed).

Kuroda, Ishii, Uematsu, Ohata, Coban, Akira, Aritake, Urade, Morimoto: "Silica crystals and aluminum salts regulate the production of prostaglandin in macrophages via NALP3 inflammasome-independent mechanisms." dans: Immunity, Vol. 34, Issue 4, pp. 514-26, (2011) (PubMed).

Blish, Clausen, Hawkins, Garvin, Willingham, Turner, Torti, Torti: "Loss of heterozygosity and SOSTDC1 in adult and pediatric renal tumors." dans: Journal of experimental & clinical cancer research : CR, Vol. 29, pp. 147, (2011) (PubMed).

Heineke, Wollert, Osinska, Sargent, York, Robbins, Molkentin: "Calcineurin protects the heart in a murine model of dilated cardiomyopathy." dans: Journal of molecular and cellular cardiology, Vol. 48, Issue 6, pp. 1080-7, (2010) (PubMed).

Shi, Zhang, Yang, Zhang, Wei: "ROCK1 plays an essential role in the transition from cardiac hypertrophy to failure in mice." dans: Journal of molecular and cellular cardiology, Vol. 49, Issue 5, pp. 819-28, (2010) (PubMed).

Wang, Hirschberg: "Diabetes-relevant regulation of cultured blood outgrowth endothelial cells." dans: Microvascular research, Vol. 78, Issue 2, pp. 174-9, (2009) (PubMed).

Aligo, Jia, Manna, Konan: "Formation and function of hepatitis C virus replication complexes require residues in the carboxy-terminal domain of NS4B protein." dans: Virology, Vol. 393, Issue 1, pp. 68-83, (2009) (PubMed).

von Hattingberg, Brockmeier: "The pharmacokinetic basis of optimal antibiotic dosage." dans: Infection, Vol. Suppl 1, pp. 21-4, (1980) (PubMed).

Détails sur GAPDH

Antigène: GAPDH (Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH))

Autre désignation: GAPDH (GAPDH Produits)

Synonymes: anticorps G3PD, anticorps GAPD, anticorps Gapd, anticorps BEST:GH12586, anticorps CG12055, anticorps Dmel\\CG12055, anticorps GA3PDH, anticorps GADPH, anticorps GAP, anticorps GAPDH, anticorps GAPDH I, anticorps GAPDH-1, anticorps GAPDH1, anticorps GAPDHI, anticorps Gapdh, anticorps Gapdh-1, anticorps Gapdh43E, anticorps gadph, anticorps gapdh, anticorps gapdh-1, anticorps gh12586, anticorps cb609, anticorps gapd, anticorps mg:bb02e05, anticorps wu:fb33a10, anticorps wu:ft80f05, anticorps KNC-NDS6, anticorps g3pd, anticorps G3PDH, anticorps glyceraldehyde-3-phosphate dehydrogenase, anticorps Glyceraldehyde 3 phosphate dehydrogenase 1, anticorps glyceraldehyde-3-phosphate dehydrogenase S homeolog, anticorps glyceraldehyde-3-phosphate dehydrogenase, type I, anticorps olfactory receptor 8K3, anticorps GAPDH, anticorps Gapdh, anticorps Gapdh1, anticorps gapdh, anticorps gapdh.S, anticorps gapDH, anticorps LOC100404960, anticorps LOC614985

Sujet: Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) is an enzyme that catalyzes the sixth step of glycolysis and thus serves to break down glucose for energy and carbon molecules. In addition to this long established metabolic function, GAPDH has recently been implicated in several non-metabolic processes, including transcription activation, initiation of apoptosis, and ER to Golgi vesicle shuttling. Synonyms: Monoclonal GAPDH antibody, Anti-GAPDH antibody, Glyceraldehyde-3-phosphate dehydrogenase antibody, GAPDH Loading Control antibody.